Introduction
Diabetes rates are increasing around the world, mainly driven by increasing levels of obesity (1) . Over the past three decades, the number of people with diabetes mellitus (DM) has more than doubled globally, making it one of the most important public health challenges to all nations. Type-2 diabetes mellitus (T2DM) and prediabetes are increasingly observed among children, adolescents and younger adults. The causes of the epidemic of T2DM are embedded in a very complex group of genetic and epigenetic systems interacting within an equally complex societal framework that determines behavior and environmental influences. Prevention of T2DM is a 'whole-of-life' task and requires an integrated approach operating from the origin of the disease. It affects more than 300 million individuals in the world with significant morbidity and mortality worldwide (2) . In parallel to the increase in the prevalence of DM, there has been a resurgence of vitamin D (vit D) deficiency worldwide (3, 4) . Though the most well-known role of vit D is the regulation of calcium (Ca) absorption and bone metabolism, it is becoming clear that this hormone has pleiotropic effects with possible role in human health including cancer, autoimmune, infectious, respiratory, and cardiovascular disease (5) (6) (7) (8) (9) .
Hypovitaminosis D has recently emerged as one of the factors contributing to the development of both type-1 and type-2 DM (10-13). Serum 25 (OH) vitamin D (25-OHD) concentrations were reported to be lower in patients with type-2 DM as compared to non-diabetic controls (14) . Since then, many crosssectional and case-control studies have shown an association between 25-OHD concentrations and type-2 DM (10-13). Vit D is a steroid hormone that has a crucial role in the modulation of bone homeostasis. It has been described as a wonder vitamin because of its possible benefits related to diverse health outcomes including bone disease, coronary heart disease, and type-2 diabetes (15, 16 (16) , as it may be the result of residual confounding, which is plausible in observational studies of incident type-2 diabetes. Measurements of confounders (e.g., physical activity) are susceptible to errors and are not adequately controlled for in epidemiological studies (17) . Although results from clinical trials (19, 20) have shown no effect of vit D supplementation on the incidence of type-2 diabetes, these findings require cautious interpretation because of issues with doses, combination treatment with calcium, compliance, and suitable conditions for generalization (15) .
There is no mention in the available literature to our knowledge regarding the circadian variation (A daily cycle of biological activity based on a 24-h period and influenced by regular variations in the environment, such as the alternation of night and day) of serum 25-OHD concentrations in diabetic patients. The present study was planned to provide reference values for circadian changes of serum vit D, Ca and Phosphorus (P) in clinical health and to assess any deviation from such norms in diabetic patients in an attempt to understand the role of Ca and vit D in the management and treatment of type-2 DM. Nagar, Dehradun, India. Two groups of subjects were investigated: a study group of 10 newly diagnosed patients (6 men; 4 women), 30 to 60 years of age, and a control group of 10 age matched clinically healthy volunteers (7 men and 3 women). This study was approved by Institutional Ethics Committee. The patients were thoroughly examined to ensure the absence of any other disease known to alter the status and rhythm of the variables examined herein. Prior to the collection of blood samples, participants refrained from taking any drug preparation that would affect or alter the Ca-vit D metabolism. All participants were kept (synchronized) for 1 week to a schedule of diurnal activity from about 06:00 to about 22:00 and nocturnal rest. All subjects took their usual (although not identical) meals three times daily: breakfast around 08:30, lunch around 13:30 and dinner around 20:30, without any change in their fluid intake. At 06:00, 12:00, 18:00 and 00:00, 6 mL of blood was collected from each subject in plain and sterile vials. The serum was separated and analyzed for Ca, P and 25-OHD, using VTROS 5.1 FS (Fusion) chemistry autoanalyzer and VITROS EciQ immunoassay analyzer and commercial kits supplied from Ortho Clinical Diagnostics, India -a division of Johnson & Johnson, USA.
Materials and Methods

Study design
Statistical analysis
Data were evaluated by conventional statistical analyses and by single and population-mean-cosinor procedures (21) (22) (23) . Accordingly, the MESOR (Midline Estimating Statistic of Rhythm, a rhythm-adjusted mean), the circadian double amplitude (a measure of the extent of predictable change within a day) and the circadian acrophase (a measure of the timing of overall high values recurring each day) were determined. Furthermore, parameter tests were performed to compare each variable between healthy subjects and DM patients.
Results and Discussion
A circadian rhythm was demonstrated for serum vit D in healthy volunteers (p = 0.030) by populationmean cosinor analysis. Similarly, a circadian rhythm of borderline statistical significance was also demonstrated for vit D in patients (p = 0.083), and in healthy subjects for Ca (p = 0.070), P (p = 0.102), and the Ca-P ratio (p = 0.091) ( Table 1) . Serum 25-OHD concentration was maximum at 12:00 and minimum at 06:00 in diabetic patients as well as in healthy volunteers. Serum 25-OHD concentrations were numerically lower at all sampling times in patients in comparison to healthy subjects. Whereas the MESOR was not statistically amplitude as a percentage of the MESOR, with a (A, φ) pair difference found for Ca (p = 0.026) and for P (p = 0.083). In this case, a difference in (A, φ) pair is also of borderline statistical significance for the C-P product (p = 0.072). Phase tests do not show any statistically significant difference between the two groups, except for the Ca/P ratio (p = 0.041).
A marked circadian variation in serum vit D concentration in healthy volunteers (p = 0.030) with a borderline statistical significance in patients (p = 0.083) was found. The MESOR and the circadian double amplitude were lower in the patients who had a similar circadian acrophase as the healthy subjects. A lower MESOR and smaller circadian amplitude in diabetic patients has not been previously reported to our knowledge. However, hypovitaminosis D has been reported in both type-1 and type-2 diabetic patients (10) (11) (12) (13) 14) . A borderline statistically significant circadian rhythm was also noticed for serum Ca, P and the Ca-P ratio in healthy volunteers. Altered vit D and calcium homeostasis may play a role in the development of type-2 diabetes. Vit D and calcium intakes were inversely associated with development of type-2 diabetes, and the benefits of the two nutrients appear to be additive. For both vit D and calcium, intakes from supplements rather than from diet were significantly associated with a lower risk of type-2 diabetes (24) . The significantly different between the patients and the healthy controls, the circadian double amplitude was smaller in the patients (1.38 vs. 2.72). The circadian acrophase of serum calcium occurred later in the patients (19:12 vs. 11:15) . The double circadian amplitude of serum phosphorus was smaller in the patients and the circadian acrophase occurred almost 14 h later in the diabetic patients in comparison to healthy counterparts. The circadian double amplitude of the Ca-P product was numerically larger in diabetic patients and the circadian acrophase occurred later (at 19:12 vs. 06:39) as compared to healthy controls. The MESOR of the Ca-P ratio was numerically higher in the patients, while the circadian double amplitude was numerically smaller. The circadian acrophase of Ca-P ratio occurred statistically significantly later in the diabetic patients.
Parameter tests were performed to compare each variable between healthy subjects and DM patients.
The tests were carried out in 3 ways: first, by using the actual M, A, O estimates; second, by expressing the amplitude as a percentage of the MESOR; and third, by equating amplitudes to 1, thus restricting the test to be an acrophase test (Table 2 ). Using the original rhythm parameters, a difference in the (A, φ) pair is found for Ca (p = 0.029), the patients having a later phase and a smaller amplitude. A similar difference in (A, φ) pair is also of borderline statistical significance for P (p = 0.084). Similar results are obtained after expressing the Table 1 . Circadian variation of plasma calcium (mg/dL), phosphorus (mg/dL) and vitamin D (ng/mL) in patients with type-2 diabetes mellitus and age-matched healthy controls
Clinical health
Diabetes mellitus Variable Ca P Vit D CaxP Ca: P Ca: Calcium; P: Phosphorus; Vit D: Vitamin D; CaxP: Ca-P product; Ca/P: Ca-P ratio; PR: percent rhythm, average proportion of variance accounted for by fi t of 24-h cosine curve to individual data series; p: p-value from zero amplitude (no-rhythm) test; M: MESOR, a rhythm adjusted mean value; 2A: double circadian amplitude, measure of extent of predictable change within a day; Ø: acrophase, measure of the timing of overall high recurring each day, expressed in (negative) degrees with 360° = 24 h and 0° = 00:00; CI: 95% Confi dence Interval. (25, 31) . The mechanisms by which calcium intake may alter diabetes risk are speculative. Abnormal regulation of intracellular calcium affecting both insulin sensitivity and insulin release has been suggested as a potential mechanism to account for the putative association between calcium insufficiency and risk of diabetes (32) . The active form of vit D, 1α, 25-(OH)2D3, has been associated with metabolism control, cell growth, differentiation, antiproliferation, apoptosis, and adaptive/innate immune responses, besides its functions in the integrity of bone and calcium homeostasis. Therefore, insufficient calcium absorption may be the culprit mechanism for the observed associations in our study, either due to vit D insufficiency (from low intake) or low calcium intake. This hypothesis is further supported by data indicating that calcium is essential in normalizing glucose intolerance due to vit D deficiency in vivo (33) . An important role of 1α, 25-(OH) 2D3 has recently been reported in the regulation of molecular clock (34) . The delayed circadian acrophase of serum Ca and P and the lower MESOR and reduced circadian amplitude of vit D in type-2 diabetic patients, as observed in the present study, may play a role in the development of the disease and become a responsible risk factor deserving further investigation.
